For ImmPact’s new CEO, Camarillo biotech company checked all the boxes
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Opinion: Everyone benefits when vaccinations are widespread
By Paul D. Witman, Jim Prior and Chris Njunge Just over two years into the COVID-19 pandemic, and well into the biggest surge, we find humanity both amazingly fortunate and still at significant risk. Vaccines, in many forms, from many sources, are generally safe and remarkably effective at reducing infection and transmission and minimizing illness. Read More →
Street Smarts: Another honor for Westlake Village BioPartners co-founder
The Healthcare Businesswomen’s Association has named Beth Seidenberg of Westlake Village BioPartners as its 2022 Woman of the Year. She will be feted live and virtually at the HBA’s annual conference in New York City on May 10. Seidenberg “has medicine in her blood,” a statement from the association says, noting that as a researcher Read More →
Cities move toward permanent outdoor dining
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Blood banks report severe shortages
With winter storms across the country and the recent COVID-19 surge, a “national blood crisis” is stressing the fragile health system devastated by the pandemic and prompting nonprofits leading collection efforts to put out a call for blood donations. Vitalant, the nation’s largest independent nonprofit blood bank, said in a Jan. 10 news release that Read More →
Health care providers deal with yet another COVID wave
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
New CEO, new board chair, new funding for ImmPact Bio
Camarillo-based ImmPact Bio made multiple headlines with one announcement on Jan. 20: the a new CEO, a new board chair, and the closing of a $111 million Series B funding round. ImmPact, a biotechnology company developing cancer treatments based on chimeric antigen receptor (CAR) T-cell therapies, named Sumant Ramachandra as its new president and CEO. Read More →
